Table of Contents
PPT Slide
Legal statement
PPT Slide
PPT Slide
Corporate highlights
Product launches
Oral: Paxil® CR
Sales forecasts for Paxil® CR
DepoCyt®
Topical: Solaraze®
Oral: Xatral® OD
Good pipeline progress
DepoMorphine™ – proprietary product
Inhalation: Foradil®
Injectable: DepoBupivacaine
New product development
New product development
Inhalation: Pulmicort® MDI
Injectable: Psoraxine™
Corporate agreements
Solubility / RTP acquisition
Key pipeline products
PPT Slide
Turnover
Turnover
R&D
Operating result
Operating result H1/H2
Cash
Cash flow
Financial summary
Newsflow 2002
PPT Slide
|